Q'Apel Medical

Executive Summary

Q'Apel Medical is a private medical device company headquartered in Fremont, California, focused on revolutionizing neurovascular access through innovative, minimally invasive technologies. Founded in 2015, the company operates at the intersection of medical devices and neuroscience, aiming to improve the safety and efficacy of procedures for treating neurological conditions such as stroke and aneurysms. By developing novel access systems, Q'Apel seeks to address unmet needs in endovascular therapy, potentially reducing procedure times and improving patient outcomes. While specific product details and financials are limited, the growing neurovascular market and the company's targeted innovation position it as a promising player in the space.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for lead product60% success
• Q2 2027Series B or later-stage funding round70% success
• Q3 2027Strategic partnership with a larger neurovascular company40% success